Dyadic International Inc DYAI:NASDAQ

RT Quote | NASDAQ | USD
Last | 04/16/21 EDT
5.01quote price arrow down-0.08 (-1.57%)
Volume
97,374
52 week range
4.56 - 10.98

...

Loading . . .
  • Open5.14
  • Day High5.19
  • Day Low4.86
  • Prev Close5.01
  • 52 Week High10.98
  • 52 Week High Date06/26/20
  • 52 Week Low4.56
  • 52 Week Low Date03/17/21

Key Stats

  • Market Cap138.03M
  • Shares Out27.55M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta0.02
  • YTD % Change-6.88

KEY STATS

  • Open5.14
  • Day High5.19
  • Day Low4.86
  • Prev Close5.01
  • 52 Week High10.98
  • 52 Week High Date06/26/20
  • 52 Week Low4.56
  • 52 Week Low Date03/17/21
  • Market Cap138.03M
  • Shares Out27.55M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta0.02
  • YTD % Change-6.88

RATIOS/PROFITABILITY

  • EPS (TTM)-0.34
  • P/E (TTM)-14.76
  • Fwd P/E (NTM)23.86
  • EBITDA (MRQ)-9.963M
  • ROE (MRQ)-29.00%
  • Revenue (MRQ)1.60M
  • Gross Margin (MRQ)11.05%
  • Net Margin (MRQ)-582.13%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/12/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Dyadic International Inc

There is no recent news for this security.

Profile

MORE
Dyadic International, Inc. is a global biotechnology company. The Company is focused on developing and licensing the C1 platform for use in human and animal pharmaceutical applications across the world. The Company has developed a method for producing commercial quantities of enzymes and other proteins, which it uses to develop and produce some of its own industrial enzymes, as well as licensing this technology to third parties. This technology is based on the Myceliopthora...
Michael Tarnok
Chairman
Mark Emalfarb
President
Ping Rawson CPA
Chief Financial Officer
Address
140 Intracoastal Pointe Dr Ste 404
Jupiter, FL
33477-5094
United States

Top Peers

SYMBOLLASTCHG%CHG
SIOX
Sio Gene Therapies Inc
2.45-0.02-0.81%
LYRA
Lyra Therapeutics Inc
10.47-0.36-3.32%
NBSE
NeuBase Therapeutics Inc
6.06-0.44-6.77%
EYEN
Eyenovia Inc
5.05-0.33-6.23%
SYBX
Synlogic Inc
3.40+0.24+7.59%